ImmunityBio (IBRX) Interest & Investment Income (2015 - 2021)
ImmunityBio's (IBRX) quarterly Interest & Investment Income came in at $112000.0 in Q2 2021, up 333.33% year-on-year from $25846.2 in Q2 2020, and down 98.75% on a QoQ basis from $8.9 million in Q1 2021.
ImmunityBio (IBRX) Interest & Investment Income (2015 - 2021) Analysis & Trends
ImmunityBio (IBRX) has 7 years of Interest & Investment Income data on file, last reported at $112000.0 in Q2 2021.
- On a quarterly basis, Interest & Investment Income rose 333.33% year-over-year to $112000.0 in Q2 2021; TTM through Jun 2021 was $9.6 million, a 1127.78% increase from a year earlier, with the FY2020 full-year figure at $1.2 million, down 24.95% from the prior year.
- Interest & Investment Income for Q2 2021 stood at $112000.0, down from $8.9 million in the prior quarter.
- Over the last five years, Interest & Investment Income for IBRX reached as high as $8.9 million in Q1 2021 and fell as low as -$5.0 million in Q4 2017.
- Historically, Interest & Investment Income has averaged $585611.1 across 5 years, with a median of $440000.0 in 2018.
- Across the five-year window, Interest & Investment Income plunged 609.93% in 2017 and surged 11366.67% in 2021, its largest moves.
- Year by year, Interest & Investment Income stood at -$5.0 million in 2017, then soared by 117.48% to $875000.0 in 2018, then slumped by 63.66% to $318000.0 in 2019, then surged by 187.42% to $914000.0 in 2020, then plunged by 87.75% to $112000.0 in 2021.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $112000.0 in Q2 2021, $8.9 million in Q1 2021, and $914000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | ImmunityBio | 7.35 Bn | 6.97 Bn | 43.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 112,000.00 |
| Mar 31, 2021 | 8.94 Mn |
| Dec 31, 2020 | 914,000.00 |
| Sep 30, 2020 | -381,000.00 |
| Jun 30, 2020 | -48,000.00 |
| Mar 31, 2020 | 78,000.00 |
| Dec 31, 2019 | 318,000.00 |
| Sep 30, 2019 | 433,000.00 |
| Jun 30, 2019 | 42,000.00 |
| Mar 31, 2019 | -40,000.00 |
| Dec 31, 2018 | 875,000.00 |
| Sep 30, 2018 | 447,000.00 |
| Jun 30, 2018 | 632,000.00 |
| Mar 31, 2018 | 505,000.00 |
| Dec 31, 2017 | -5.01 Mn |
| Sep 30, 2017 | 680,000.00 |
| Jun 30, 2017 | 681,000.00 |
| Mar 31, 2017 | 1.35 Mn |
| Dec 31, 2016 | -705,000.00 |
| Sep 30, 2016 | -625,000.00 |